Virology Market By Type 2023 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Virology Market
Virology Market: By Type (Diagnosing Test, Viral Infection Controlling Methods & others); By Application (Skin & Soft Tissue Infections, Respiratory Tract Infections & others); By End-User (Hospitals, Clinics, Laboratories & others) & By Region - (2015-2023)
Report Code : HCR 0423
Updated Date: 15 September, 2017  

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
1. Virology Market – Overview
2. Executive Summary 
3. Virology Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Virology Market– Forces
   4.1. Drivers
      4.1.1. Increasing incidences of global viral epidemics
      4.1.2. Growing applications of virology research in gene therapy, phage therapy, formulation of vaccines, and synthetic biology
   4.2. Restraints
   4.3. Opportunities
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Virology Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Virology Market, By Type
   6.1. Diagnosing Test
   6.2. Viral Infection Controlling Methods
   6.3. Antiviral Chemotherapy
   6.4. Interferons
7. Virology Market, By Application
   7.1. Skin and Soft Tissue Infections
   7.2. Respiratory Tract Infections
   7.3. GI Tract Infections
   7.4. Urinary Tract Infections
   7.5. Eye Infections
   7.6. CNS Infections
   7.7. Sexually Transmitted Diseases
   7.8. Perinatal Infections
8. Virology Market, By End-User 
   8.1. Hospitals
   8.2. Clinics
   8.3. Laboratories
   8.4. Diagnostic Centres
   8.5. Blood Banks
   8.6. Pharmacies
9. Virology Market, By Geography
   9.1. Europe
      9.1.1. Germany
      9.1.2. France
      9.1.3. Italy
      9.1.4. Spain
      9.1.5. Russia
      9.1.6. U.K.
      9.1.7. Rest of Europe
   9.2. Asia Pacific
      9.2.1. China
      9.2.2. India
      9.2.3. Japan
      9.2.4. South Korea
      9.2.5. Rest of Asia-Pacific
   9.3. North America 
      9.3.1. U.S.
      9.3.2. Canada
      9.3.3. Mexico
   9.4. Rest of the World (RoW)
      9.4.1. Brazil
      9.4.2. Rest of RoW
10. Virology Market – Entropy
   10.1. Expansion
   10.2. Technological Developments
   10.3. Merger & Acquisitions, and Joint Ventures
   10.4. Supply- Contract
11. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   11.1. GlaxoSmithKline plc
   11.2. Abbott Laboratories
   11.3. Boehringer Ingelheim Corporation
   11.4. Merck and Co. Inc.
   11.5. Novartis International AG
   11.6. Siemens
   11.7. Johnson & Johnson
   11.8. AstraZeneca AB
   11.9. Roche
   11.10. Abivax
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
12. Appendix
   12.1. Abbreviations
   12.2. Sources
   12.3. Research Methodology
   12.4. Bibliography
   12.5. Compilation of Expert Insights
   12.6. Disclaimer
Virology is a branch of microbiological or pathological science which involves the study of viruses and virus-like agents. Virology focuses on the following aspects of viruses: their structure, classification and evolution, their ways to infect and exploit host cells for reproduction, their interaction with host organism physiology and immunity, the diseases they cause, the techniques to isolate and culture them, and their use in research and therapy. Globally, increasing instances of viral epidemic breakouts and huge R&D investment by major players are expected to remain key growth drivers for virology during the period of study.

Virology Market
 
Geographically, North America dominated the virology market driven by world class healthcare infrastructure with a technologically advanced practice, higher spending and presence of key industry players in the region. North America was followed by Europe and Asia-Pacific as second and third largest market for virology market. Asia Pacific is projected to have the fastest growth, owing to a rapidly developing medical infrastructure, increasing spending on healthcare and growing medical tourism in developing nations such as China and India in this region.

This report identifies the virology market size for the years 2014-2016, and forecast of the same till the year 2022. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to the virology market.

This report segments the virology market on the basis of type, application, end-user and regional market as follows:
  • Virology market research report is classified on the basis of type. Some of the major types covered in this report are as follows: Diagnosing Test, Viral Infection Controlling Methods, Antiviral Chemotherapy, Interferons
  • Virology market research report is classified on the basis of application. Some of the major applications covered in this report are as follows: Skin and Soft Tissue Infections, Respiratory Tract Infections, GI Tract Infections, Urinary Tract Infections, Eye Infections, CNS Infections, Sexually Transmitted Diseases, Perinatal Infections
  • Virology market research report is classified on the basis of end-users. Some of the major end-users covered in this report are as follows: Hospitals, Clinics, Laboratories, Diagnostic Centres, Blood Banks, Pharmacies
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the virology market. Some of the major companies’ profiles in detail are as follows:
  • GlaxoSmithKline plc
  • Abbott Laboratories
  • Boehringer Ingelheim Corporation
  • Merck and Co. Inc.
  • Novartis International AG
List of Tables:

Table 1: HIV Statistics, 2016 (In Millions)
Table 2: Virology Market Revenue, By End Use, 2016-2023 ($Million)
Table 3: Europe: Virology Market, By Type, 2016-2023 ($Million)
Table 4: Europe: Virology Market, By Application, 2016-2023 ($Million)
Table 5: Europe: Virology Market, By End User, 2016-2023 ($Million)
Table 6: Europe: Virology Market, By Country, 2016-2023 ($Million)
Table 7: Germany: GDP – Composition of 2016, By End Use
Table 8: France: GDP – Composition of 2016, By End Use
Table 9: Italy: GDP – Composition of 2016, By End Use
Table 10: Spain: GDP – Composition of 2016, By End Use
Table 11: GDP – Composition of 2016, By End Use
Table 12: U.K.: GDP – Composition of 2016, By End Use
Table 13: APAC Virology Market Value, By Type (2015-2023), $Million
Table 14: APAC Virology Market Value, By Application (2015-2023), $Million
Table 15: APAC Virology Market Value, By End User (2015-2023), $Million
Table 16: APAC Virology Market Value, By Country (2015-2023), $Million
Table 17: North America Virology Market Value, By Type (2015-2023), $Million
Table 18: North America Virology Market Value, By Application (2015-2023), $Million
Table 19: North America Virology Market Value, By End User (2015-2023), $Million
Table 20: North America Virology Market Value, By Country (2015-2023), $Million
Table 21: Row: Virology Market, By Type, 2016-2023 ($Million)
Table 22: Row: Virology Market, By Application, 2016-2023 ($Million)
Table 23: Row: Virology Market, By End User, 2016-2023 ($Million)
Table 24: Row: Virology Market, By Region, 2016-2023 ($Million)


List of Figures:

Figure 1: Virology Market Revenue, 2016, 2023 ($Million)
Figure 2: Virology Market, Growth Rate, By Application (%)
Figure 3: Virology Market Share, By Geography, 2016 (%)
Figure 4: Virology Market Share, By Geography, 2023 (%)
Figure 5: Virology Market Share, By Company, 2016 (%)
Figure 6: Global Influenza Patents Granted, 2013-2017 (Units)
Figure 7: Global Influenza Patent Granted Share, By Country, 2013-2017 (%)
Figure 8: Global HIV/HPV Patents Granted, 2013-2017 (Units)
Figure 9: Global HIV/HPV Patent Granted Share, By Country, 2013-2017 (%)
Figure 10: Global STD/STI Patents Granted, 2013-2017 (Units)
Figure 11: Global STD/STI Patent Granted Share, By Country, 2013-2017 (%)
Figure 12: F. Hoffmann-La Roche Ltd.
Figure 13: Abbott
Figure 14: Danaher Corp.
Figure 15: Siemens AG
Figure 16: Becton Dickinson and Co
Figure 17: Earnings Per Share ($/Share), By Company
Figure 18: Viral Load test forecast, (2011-2028)
Figure 19: Virology Market Life Cycle, 2015-2021
Figure 20: Viral Load test forecast, (2011-2028)
Figure 21: Diagnosing Test: Virology Market Revenue, 2015-2023 ($Million)
Figure 22: Viral Infection Controlling Methods: Virology Market Revenue, 2015-2023 ($Million)
Figure 23: Global Anti-Viral Chemotherapy Market Value, By Type (2015-2023), $Million
Figure 24: Global Interferons Market Value, By Type (2015-2023), $Million
Figure 25: Global Prophylaxis Market Value, By Type (2015-2023), $Million
Figure 26: Virology Market, By Application
Figure 27: Virology Market Revenue Share, By Application, 2016 (%)
Figure 28: Skin disease related deaths per 100,000, By Country (Units)
Figure 29: Skin and Soft Tissue Infections Virology Market Revenue, 2016-2023 ($Million)
Figure 30: Deaths due to Lung Disease per 100,000 individuals, By Country (Units)
Figure 31: Respiratory Tract Infections Virology Market Revenue, 2016-2023 ($Million)
Figure 32: Global Deaths due to diarrheal diseases, 2015(units)
Figure 33: GI Tract Infections Virology Market Revenue, 2016-2023 ($Million)
Figure 34: Patents for Urinary Tract Infections, 2012-2017, (Units)
Figure 35: Urinary Tract Infections Virology Market Revenue, 2016-2023 ($Million)
Figure 36: Viral Eye Infections, Patents Granted, 2015-2017 (Units)
Figure 37: Eye Infections Virology Market Revenue, 2016-2023 ($Million)
Figure 38: Types of Viral CNS Diseases, by %
Figure 39: CNS Infections Virology Market Revenue, 2016-2023 ($Million)
Figure 40: Sexually Transmitted Infections Virology Market Revenue, 2016-2023 ($Million)
Figure 41: Perinatal Infections Virology Market Revenue, 2016-2023 ($Million)
Figure 42: Crude age-specific HPV prevalence (%) in Asian Women, 2015
Figure 43: HIV/HPV Virology Market Revenue, 2016-2023 ($Million)
Figure 44: Number of positive Influenza cases in China & U.S., 2015
Figure 45: Influenza Virology Market Revenue, 2016-2023 ($Million)
Figure 46: Others Virology Market Revenue, 2016-2023 ($Million)
Figure 47: Virology Market Segmentation, By End Use
Figure 48: Regions with registered number of hopitals under WHO
Figure 49: Hospitals: Virology Market Revenue, 2016-2023 ($Million)
Figure 50: Dramatic Decline in Vaccine Preventable Diseases in Americas
Figure 51: Clinics: Virology Market Revenue, 2016-2023 ($Million)
Figure 52: Expenditure on Health as a percentage of GDP
Figure 53: Laboratories: Virology Market Revenue, 2016-2023 ($Million)
Figure 54: Medical Center Beds per 1000 population
Figure 55: Diagnostic Centers: Virology Market Revenue, 2016-2023 ($Million)
Figure 56: Number of Blood Donors and Laboratory tests conducted in Singapore
Figure 57: Blood Banks: Virology Market Revenue, 2016-2023 ($Million)
Figure 58: Number of Pharmacists in USA by types of diseases
Figure 59: Pharmacies: Virology Market Revenue, 2016-2023 ($Million)
Figure 60: Germany: GDP and Population, 2013-2016 ($Trillion, Million)
Figure 61: Germany: GDP – Composition of 2016, By Sector of Origin
Figure 62: Germany: Export and Import Value, 2013-2016 ($Billion)
Figure 63: France: GDP and Population, 2013-2016 ($Trillion, Million)
Figure 64: France: GDP – Composition of 2016, By Sector of Origin
Figure 65: France: Export and Import Value, 2013-2016 ($Billion)
Figure 66: Italy: GDP and Population, 2013-2016 ($Trillion, Million)
Figure 67: Italy: GDP – Composition of 2016, By Sector of Origin
Figure 68: Italy: Export and Import Value, 2013-2016 ($Billion)
Figure 69: Spain: GDP and Population, 2013-2016($Trillion, Million)
Figure 70: Spain: GDP – Composition of 2016, By Sector of Origin
Figure 71: Spain: Export and Import Value, 2013-2016($Billion)
Figure 72: Russia: GDP and Population, 2013-2016 ($Trillion, Million)
Figure 73: GDP – Composition of 2016, By Sector of Origin
Figure 74: The Russia: Export and Import Value, 2013-2016($Billion)
Figure 75: U.K.: GDP and Population, 2013-2016 ($Trillion, Million)
Figure 76: U.K.: GDP – Composition of 2016, By Sector of Origin
Figure 77: U.K.: Export and Import Value, 2013-2016 ($Billion)
Figure 78: HIV Diagnoses in Germany (2013-2015)
Figure 79: HIV Diagnoses France (2013-2015)
Figure 80: HIV Diagnoses in Spain (2013-2015)
Figure 81: U.K.: Virology Market, 2016-2023 ($Million)
Figure 82: Germany: Virology Market, 2016-2023 ($Million)
Figure 83: France: Virology Market, 2016-2023 ($Million)
Figure 84: Italy: Virology Market, 2016-2023 ($Million)
Figure 85: Russia: Virology Market, 2016-2023 ($Million)
Figure 86: Spain: Virology Market, 2016-2023 ($Million)
Figure 87: China Healthcare Expenditure as % of Total GDP
Figure 88: Japan Influenza Virus Isolation/Detection from Human Sources, 2013 - 2017
Figure 89: MERS-CoV cases in South Korea, 2015
Figure 90: Japan: Virology Market Value, 2015-2023 ($Million)
Figure 91: China: Virology Market Value, 2015-2023 ($Million)
Figure 92: South Korea: Virology Market Value, 2015-2023 ($Million)
Figure 93: India: Virology Market Value, 2015-2023 ($Million)
Figure 94: Rest of Asia Pacific: Virology Market Value, 2015-2023 ($Million)
Figure 95: Asia Pacific: Virology Market CAGR, By Country, 2017-2023 (%)
Figure 96: Seasonal Flu Vaccination Coverage, By Age Group and Season, U.S., 2009-2014
Figure 97: Total Seasonal Influenza Cases in Canada, 2000-2017*
Figure 98: Mexico Healthcare Expenditure as % of Total GDP
Figure 99: U.S.: Virology Market Value, 2015-2023 ($Million)
Figure 100: Canada: Virology Market Value, 2015-2023 ($Million)
Figure 101: Mexico: Virology Market Value, 2015-2023 ($Million)
Figure 102: North America: Virology Market CAGR, By Country, 2017-2023 (%)
Figure 103: No. of PLHIV receiving Antiretroviral therapy(ART) in South Africa (2010-2014)
Figure 104: Middle East: Virology Market, 2016-2023 ($Million)
Figure 105: Africa: Virology Market, 2016-2023 ($Million)
Figure 106: Siemens Aktiengesellschaft Net Revenue, By Years, 2014-2016 ($Billion)
Figure 107: Siemens Aktiengesellschaft Net Sales Share, By Business Segments, 2016 (%)
Figure 108: Siemens Aktiengesellschaft Net Sales Share, By Geography, 2016 (%)
Figure 109: Johnson & Johnson Net Revenue, By Years, 2014-2016 ($Billion)
Figure 110: Johnson & Johnson Net Sales Share, By Business Segments, 2016 (%)
Figure 111: Johnson & Johnson Net Sales Share, By Geography, 2016 (%)
Figure 112: Roche Holding AG Net Revenue, By Years, 2014-2016 ($Billion)
Figure 113: Roche Holding AG Net Sales Share, By Business Segments, 2016 (%)
Figure 114: AstraZeneca AB Net Revenue, By Years, 2014-2016 ($Billion)
Figure 115: AstraZeneca AB Net Sales Share, By Product Segments, 2016 (%)
Figure 116: AstraZeneca AB Net Sales Share, By Geography, 2016 (%)
Figure 117: Abbott. Net Sales, By Years, 2014-2016 ($Million)
Figure 118: Abbott. Net Sales Share, By Business Segments, 2016 (%)
Figure 119: Abbott. Net Revenue Share, By Geography, 2016 (%)
Figure 120: GlaxoSmithKline plc. Net Sales, By Years, 2014-2016 ($Billion)
Figure 121: GlaxoSmithKline plc. Net Sales Share, By Business Segments, 2016 (%)
Figure 122: GlaxoSmithKline plc. Net Revenue Share, By Geography, 2016 (%)
Figure 123: Merck & Co., Inc. Net Sales, By Years, 2014-2016 ($Million)
Figure 124: Merck & Co., Inc. Net Sales Share, By Business Segments, 2016 (%)
Figure 125: Merck & Co., Inc. Net Revenue Share, By Geography, 2016 (%)
Figure 126: Novartis AG Net Sales, By Years, 2014-2016 ($Billion)
Figure 127: Novartis AG Net Sales Share, By Business Segments, 2016 (%)
Figure 128: Novartis AG Net Revenue Share, By Geography, 2016 (%)
Figure 129: Qaigen Net Sales, By Years, 2014-2016 ($Million)
Figure 130: Qaigen Net Sales Share, By Business Segments, 2016 (%)
Figure 131: Qaigen Net Revenue Share, By Geography, 2016 (%)
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll